KEXING BIOPHARM CO., LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of 688136 for the last quarter is 357.47 M CNY, and it's 24.73% higher compared to the previous quarter. The net income of Q1 24 is 12.40 M CNY.